Page last updated: 2024-11-03

procainamide and Disorders of Excessive Somnolence

procainamide has been researched along with Disorders of Excessive Somnolence in 1 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Disorders of Excessive Somnolence: Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coccagna, G1
Mantovani, M1
Parchi, C1
Mironi, F1
Lugaresi, E1

Other Studies

1 other study available for procainamide and Disorders of Excessive Somnolence

ArticleYear
Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.
    Journal of neurology, neurosurgery, and psychiatry, 1975, Volume: 38, Issue:10

    Topics: Aminobutyrates; Disorders of Excessive Somnolence; Humans; Hypoventilation; Male; Middle Aged; Muscl

1975